 |
|
Combination Antidepressant Therapy in Primary Care
Dana E. King, MD;
Douglas H. Finestone, MD;
James G. Peden, MD
Arch Fam Med. 1994;3(12):1088-1092.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Grimsley SR, Jann MW. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors. Clin Pharm. 1992;11:930-957.
PUBMED
2. Caley CF, Weber SS. Paroxetine: a selective serotonin reuptake inhibiting antidepressant. Ann Pharmacother. 1993;27:1212-1222.
ABSTRACT
3. Calabrese JR, Markovitz PJ. Treatment of depression: new pharmacologic approaches. Primary Care. 1991;18:421-433.
PUBMED
4. Zarifan E, Rigal F. New antidepressants and trends in the pharmacotherapy of depressive disorders. Psychiatry Clin North Am. 1982;6:129-139.
5. Combining the antidepressant drugs. Lancet. 1965;2:118. Editorial.
6. Gander DR. Treatment of depressive illnesses with combined antidepressants. Lancet. 1965;2:107-109.
7. Sargant W. Combining the antidepressant drugs. Lancet. 1963;2:634-635.
PUBMED
8. Zajecka JM, Jawcett J. Antidepressant combination and potentiation. Psychiatric Med. 1991;9:55-75.
9. Nierenberg AA, White K. What next? a review of pharmacologic strategies for treatment-resistant depression. Psychopharmacol Bull. 1990;26:429-460.
PUBMED
10. Jacobsen FM. Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study. J Clin Psychiatry. 1990;51:298-302.
PUBMED
11. Nierenberg AA, Keck PE. Management of monoamine oxidase inhibitor-associated insomnia with trazodone. J Clin Psychopharmacol. 1989;9:42-45.
PUBMED
12. Nierenberg AA, Cole JO, Glass L. Possible trazodone potentiation of fluoxetine: a case series. J Clin Psychiatry. 1992;53:83-85.
PUBMED
13. Weilburg JB, Rosenbaum JF, Meltzer-Brody S, Shushtari J. Tricyclic augmentation of fluoxetine. Ann Clin Psychiatry. 1991;3:209-213.
14. Nelson JC, Mazure CM, Bowers MB, Jatlow PI. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry. 1991;48:303-307.
FREE FULL TEXT
15. Rosenthal JS, Kaswan MJ, Hemlock C, Winston A. Fluoxetine enhancement of heterocyclic antidepressants. In: Amsterdam JD, ed. Advances in Neuropsychiatry and Psychopharmacology. New York, NY: Raven Press Ltd; 1991;2:105-108.
16. Weilburg JB, Rosenbaum JF, Beiderman J, Sachs GS, Pollack MH, Kelly K. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989;50:447-449.
PUBMED
17. Eisen A. Fluoxetine and desipramine: a strategy for augmenting antidepressant response. Pharmacopsychiatry. 1989;22:272-273.
PUBMED
18. Lydiard RB, Anton RF, Cunningham T. Interactions between sertraline and tricyclic antidepressants. Am J Psychiatry. 1993;150:1125-1126.
PUBMED
19. Gerner R. Rational polydrug use in psychiatry. West J Med. 1991;155:518.
PUBMED
20. Baron BM, Ogden AM, Seigel BW, Stegeman J, Ursillo RC, Dudley MW. Rapid down regulation of β-adrenoceptors by co-administration of desipramine and fluoxetine. Eur J Pharmacol. 1988;154:125-134.
PUBMED
21. Levin GM, DeVane CL. Prescribing attitudes of different physician groups regarding fluoxetine. Ann Pharmacother. 1993;27:1443-1447.
ABSTRACT
22. Weinberger MH. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white, mild to moderate hypertensive patients. J Cardiovasc Pharmacol. 1985;7(suppl_1):S52-S55.
23. Extein IL. Recent fluoxetine treatment and complications of tricyclic therapy. Am J Psychiatry. 1991;148:1601-1602.
PUBMED
24. Westermeyer J. Fluoxetine-induced tricyclic toxicity: extent and duration. J Clin Pharmacol. 1991;31:388-392.
ABSTRACT
25. Cavanaugh SA. Drug-drug interactions of fluoxetine with tricyclics. Psychosomatics. 1990;31:273-276.
PUBMED
26. Preskorn SH, Beber JH, Faul JC, Hirschfeld RMA. Serious adverse effects of combining fluoxetine and tricyclic antidepressants. Am J Psychiatry. 1990;147:532.
PUBMED
27. Schraml F, Benedetti G, Hoyle K, Clayton A. Fluoxetine and nortriptyline combination therapy. Am J Psychiatry. 1989;146:1636-1637.
PUBMED
28. Aranow RB, Hudson JI, Pope HG, et al. Elevated antidepressant plasma levels after addition of fluoxetine. Am J Psychiatry. 1989;146:911-913.
PUBMED
29. Downs JM, Downs AD, Rosenthal TL, Deal N, Akiskal HS. Increased plasma tricyclic antidepressant concentrations in two patients concurrently treated with fluoxetine. J Clin Psychiatry. 1989;50:226-227.
PUBMED
30. Goodnick PJ. Influence of fluoxetine on plasma levels of desipramine. Am J Psychiatry. 1989;146:552.
PUBMED
31. Bell IR, Cole JO. Fluoxetine induces elevation of desipramine level and exacerbation of geriatric nonpsychotic depression. J Clin Psychopharmacol. 1988;8:447-448.
PUBMED
32. Vaughan DA. Interaction of fluoxetine with tricyclic antidepressants. Am J Psychiatry. 1988;145:1478.
PUBMED
33. Barros J, Asnis G. An interaction of sertraline and desipramine. Am J Psychiatry. 1993;150:1751.
PUBMED
34. Spina E. Campo GM, Avenoso A, Pollicino MA, Caputi AP. Interaction between fluvoxamine and imipramine/desipramine in four patients. Ther Drug Monit. 1992;14:194-196.
PUBMED
35. Bertschy G, Vandel S, Vandel B, Allers G, Volmat R. Fluvoxamine-tricyclic antidepressant interaction. Eur J Clin Pharmacol. 1991;40:119-120.
PUBMED
36. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991;148:705-713.
PUBMED
37. Depression Guideline Panel. Clinical Practice Guideline Number 5: Depression in Primary Care. Rockville, Md: Agency for Health Care Policy and Research; 1993;2. US Dept of Health and Human Services publication 93-0551.
|
